Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors.
about
Kynurenine 3-Monooxygenase: An Influential Mediator of NeuropathologyAstrocyte galectin-9 potentiates microglial TNF secretionNeurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?Deletion of ovarian hormones induces a sickness behavior in rats comparable to the effect of lipopolysaccharide.Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice.Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways.Low-Level Stress Induces Production of Neuroprotective Factors in Wild-Type but Not BDNF+/- Mice: Interleukin-10 and Kynurenic AcidInteractions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus.Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge.Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studiesImmunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the Kynurenine Pathway in the Mouse Hippocampus.Sleep disturbance and kynurenine metabolism in depression.Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases.Disrupted Tryptophan Metabolism Induced Cognitive Impairment in a Mouse Model of Sepsis-associated Encephalopathy.Serum kynurenic acid is reduced in affective psychosis.Advancing the understanding of behaviors associated with Bacille Calmette Guérin infection using multivariate analysis.The effects of Nigella sativa on sickness behavior induced by lipopolysaccharide in male Wistar rats.Lipopolysaccharide-Induced Behavioral Alterations Are Alleviated by Sodium Phenylbutyrate via Attenuation of Oxidative Stress and Neuroinflammatory Cascade.Glia- and tissue-specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone.Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.NLRP3 Inflammasome Contributes to Lipopolysaccharide-induced Depressive-Like Behaviors via Indoleamine 2,3-dioxygenase Induction.Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice.Vitamin B6 Reduces Neurochemical and Long-Term Cognitive Alterations After Polymicrobial Sepsis: Involvement of the Kynurenine Pathway Modulation.Inhibition of DNA Methylation With Zebularine Alters Lipopolysaccharide-Induced Sickness Behavior and Neuroinflammation in MiceTranslocator protein ligand, YL-IPA08, attenuates lipopolysaccharide-induced depression-like behavior by promoting neural regeneration
P2860
Q26782867-7FAC067B-9EF3-42FE-8C22-E98CB73023D4Q28567332-0DD90702-60D4-473C-9397-EF10CC55F718Q30839124-94D91CAC-6174-4871-9E70-D5C0573AF420Q34051382-1DBC9142-99E1-4684-8C5E-55FF8E5D8725Q35075256-C65C3F05-EAF0-4DAF-8084-AC4C0616E9EEQ35554122-480484E4-3663-4F58-B1DF-D3027FC3EEF4Q35755435-397C8551-FCB6-4E29-B51B-B75A4B946D8FQ36749816-85BC014A-F48F-4F35-A3E5-46A739077611Q36865674-E99F59E1-DF58-4328-8B98-968ADC1FB49CQ36945317-686D1CE1-BF40-4E58-B73E-568D380412DBQ37111098-45CA6649-3FC1-4AA2-9763-6E6975D0C09DQ37114639-B6F1512D-37C7-488A-B5E9-BB4E7747A75CQ37342523-C2641F03-42CF-4164-90BC-F3F1C019E8E8Q38676972-8CC80113-89FB-4A4E-8E58-306F4F6A9100Q38843539-11090FE5-4AC0-4D02-B86B-B2D5FD88CF08Q38954921-EC9E44E2-6E3F-4F2E-A882-621C6B5152AAQ40934701-20B053D3-A7DF-4B22-845D-FA9959413CDFQ41173215-96502EBA-E5C5-4086-A3F6-846C891994CEQ41707744-09B95A22-4F2C-4B66-ACC7-2AC2D03BF930Q42754301-2A795B5D-5F6E-49A4-BDD8-9CD2477E3E25Q47429340-E2A37612-6309-4D02-87A2-0E9F1FABA3C3Q47678641-F3E71BF7-7BAC-4262-BCE8-889372708FD6Q47722395-A4614F81-8151-4E45-8245-3A7F8B56531CQ47744128-D2700AC0-BC20-4F6E-BEDB-5B8D23E28E7BQ48061279-418320E7-D62E-461C-A88C-AFE5A984259FQ48114977-EC47C2E3-EB5F-4A9B-875F-242A8931547CQ57073777-6526619D-E9BB-468B-8347-699B4D5CE071Q58702659-078962CD-E0D9-496C-B323-7ED53B33F7B1
P2860
Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intracerebroventricular admini ...... ent depression-like behaviors.
@en
Intracerebroventricular admini ...... ent depression-like behaviors.
@nl
type
label
Intracerebroventricular admini ...... ent depression-like behaviors.
@en
Intracerebroventricular admini ...... ent depression-like behaviors.
@nl
prefLabel
Intracerebroventricular admini ...... ent depression-like behaviors.
@en
Intracerebroventricular admini ...... ent depression-like behaviors.
@nl
P2093
P2860
P356
P1476
Intracerebroventricular admini ...... ent depression-like behaviors.
@en
P2093
Jason C O'Connor
Jennifer M Parrott
Keith W Kelley
Marcus A Lawson
Robert Dantzer
Robert H McCusker
P2860
P2888
P356
10.1186/1742-2094-10-87
P577
2013-07-18T00:00:00Z
P5875
P6179
1005305531